Atossa Genetics (NASDAQ:ATOS) reported quarterly losses of $(0.06) per share. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.
RBC Capital Initiates Coverage On New Relic with Sector Perform Rating, Announces Price Target of $74
RBC Capital analyst Rishi Jaluria initiates coverage on New Relic (NYSE:NEWR) with a Sector Perform rating and announces Price Target of $74.